Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,466 | 13 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $1,202 | 10 | $0 (2019) |
| Teva Pharmaceuticals USA, Inc. | $124.76 | 1 | $0 (2019) |
| Neurocrine Biosciences, Inc. | $124.73 | 1 | $0 (2018) |
| Sunovion Pharmaceuticals Inc. | $13.77 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $485.24 | 4 | Alkermes, Inc. ($360.48) |
| 2018 | $511.62 | 5 | Alkermes, Inc. ($373.12) |
| 2017 | $468.88 | 4 | Alkermes, Inc. ($468.88) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/12/2019 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $119.78 | General |
| Category: CNS | ||||||
| 05/31/2019 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $115.74 | General |
| Category: CNS | ||||||
| 04/30/2019 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $124.76 | General |
| Category: Central Nervous System | ||||||
| 03/08/2019 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $124.96 | General |
| Category: CNS | ||||||
| 10/05/2018 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: CNS | ||||||
| 06/22/2018 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $124.73 | General |
| Category: NEUROLOGY | ||||||
| 06/08/2018 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: CNS | ||||||
| 03/14/2018 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $123.14 | General |
| Category: CNS | ||||||
| 02/20/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: CNS | ||||||
| 09/22/2017 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $123.52 | General |
| Category: CNS | ||||||
| 08/23/2017 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $110.02 | General |
| Category: CNS | ||||||
| 03/10/2017 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: CNS | ||||||
| 02/15/2017 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $110.36 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 1,655 | 6,247 | $1.9M | $343,212 |
| 2022 | 9 | 1,700 | 5,564 | $1.9M | $364,646 |
| 2021 | 8 | 1,732 | 3,711 | $1.4M | $249,288 |
| 2020 | 9 | 2,008 | 5,212 | $1.7M | $312,019 |
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99347 | Residence visit for established patient with straightforward medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 739 | 4,971 | $994,200 | $192,361 | 19.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 459 | 468 | $514,800 | $79,104 | 15.4% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 121 | 296 | $89,500 | $19,584 | 21.9% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 108 | 280 | $84,000 | $18,812 | 22.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2023 | 114 | 116 | $127,600 | $17,431 | 13.7% |
| 90791 | Psychiatric diagnostic evaluation | Office | 2023 | 63 | 65 | $61,750 | $9,391 | 15.2% |
| 90791 | Psychiatric diagnostic evaluation | Facility | 2023 | 51 | 51 | $48,450 | $6,529 | 13.5% |
| 99334 | Established patient custodial care facility, group care, or assisted living visit, typically 15 minutes | Office | 2022 | 700 | 4,313 | $1.1M | $232,175 | 21.5% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 317 | 321 | $353,100 | $56,333 | 16.0% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 115 | 254 | $76,200 | $15,664 | 20.6% |
| 96116 | Exam of neurobehavioral status, first hour | Office | 2022 | 142 | 144 | $108,000 | $12,123 | 11.2% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 71 | 170 | $51,000 | $10,835 | 21.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2022 | 58 | 58 | $63,800 | $9,022 | 14.1% |
| 99325 | New patient custodial care facility, group care, or assisted living visit, typically 30 minutes | Office | 2022 | 128 | 128 | $57,600 | $8,571 | 14.9% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Office | 2022 | 70 | 70 | $38,500 | $8,026 | 20.8% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Facility | 2022 | 41 | 41 | $22,550 | $4,861 | 21.6% |
| 90791 | Psychiatric diagnostic evaluation | Office | 2022 | 13 | 13 | $12,350 | $2,053 | 16.6% |
| 99335 | Established patient custodial care facility, group care, or assisted living visit, typically 25 minutes | Office | 2022 | 18 | 23 | $7,475 | $1,934 | 25.9% |
| 90791 | Psychiatric diagnostic evaluation | Facility | 2022 | 14 | 14 | $13,300 | $1,876 | 14.1% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 13 | 15 | $5,625 | $1,174 | 20.9% |
| 99334 | Established patient assisted living visit, typically 15 minutes | Office | 2021 | 595 | 2,377 | $594,450 | $127,025 | 21.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2021 | 182 | 184 | $202,400 | $28,779 | 14.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 128 | 129 | $141,150 | $23,438 | 16.6% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 193 | 359 | $107,700 | $20,970 | 19.5% |
| 96116 | Neurobehavioral status examination by qualified health care professional with interpretation and report, first 60 minutes | Office | 2021 | 213 | 214 | $160,500 | $18,961 | 11.8% |
About Dr. Devendra Amin, M.D
Dr. Devendra Amin, M.D is a Psychiatry healthcare provider based in Smithtown, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780696914.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Devendra Amin, M.D has received a total of $1,466 in payments from pharmaceutical and medical device companies, with $485.24 received in 2019. These payments were reported across 13 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($1,466).
As a Medicare-enrolled provider, Amin has provided services to 7,095 Medicare beneficiaries, totaling 20,734 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Smithtown, NY
- Active Since 08/13/2006
- Last Updated 09/15/2008
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1780696914
Products in Payments
- Aristada 441 mg (Drug) $842.00
- ARISTADA (Drug) $360.48
- AUSTEDO (Drug) $124.76
- INGREZZA (Drug) $124.73
- LATUDA (Drug) $13.77
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Smithtown
Bruce Rosen, Md, MD
Psychiatry — Payments: $46,082
Robert Castroll, Md, MD
Psychiatry — Payments: $20,986
Shelley Epstein, Md, MD
Psychiatry — Payments: $13,002
Suzanne Tuzel, Md, MD
Psychiatry — Payments: $9,906
Dr. Maria Benetos, Do, DO
Psychiatry — Payments: $3,293
Dr. Christopher Burke, M.d, M.D
Psychiatry — Payments: $1,541